BD Diagnostics ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â‚¬Å¡Ã‚Â¬ÃƒÂ¢Ã¢â€šÂ¬Ã…â€œ TriPath (BD Diagnostics) is a privately-held medical device company engaged in the design, development, manufacture and marketing of molecular diagnostic products for various cancers including cervical, breast, ovary and prostate. It conducts and carries out research and development activities in the fields of molecular oncology and cervical cytology. The product portfolio of the company includes BD SurePath Pap test, BD PrepStain Slide Processor, BD FocalPoint Slide Profiler and BD FocalPoint GS Imaging System. BD Diagnostics is headquartered in North Carolina, the US.
Recently, the company introduced Microtainer MAP Microtube for automated process and hematology testing. It also received FDA clearance for Amplified DNA Assays for cervical cancer screening.